Communication
Organic & Biomolecular Chemistry
Conflicts of interest
There are no conflicts to declare.
Acknowledgements
This study was supported by JSPS KAKENHI Grant Number
17K08216 (O.M.).
Scheme 3 Asymmetric α-phenylation of biologically active ketones.
Notes and references
1 (a) P. J. Harrington and E. Lodewijk, Org. Process Res. Dev.,
1997, 1, 72; (b) X. Chen, J. Z. M. Fong, J. Xu, C. Mou, Y. Lu,
S. Yang, B.-A. Song and Y. R. Chi, J. Am. Chem. Soc., 2016,
138, 7212; (c) C. Chen, H. Wang, Z. Zhang, S. Jin, S. Wen,
J. Ji, L. W. Chung, X.-Q. Dong and X. Zhang, Chem. Sci.,
2016, 7, 6669.
Scheme 4 Scalable synthesis and synthetic modification of 2a.
2 (a) G. Castaldi, G. Barreca and A. Bologna, WO 03093276,
Dinamite, Dipharma S.P.A., 2003; (b) S.-F. Zhu, Y. Cai,
H.-X. Mao, J.-H. Xie and Q.-L. Zhou, Nat. Chem., 2010, 2,
546.
3 (a) R. Rometsch, U.S. Patent, 2838519, 1958; (b) M. Prashad,
B. Hu, O. Repič, T. J. Blacklock and P. Giannousis, Org.
Process Res. Dev., 2000, 4, 55.
4 (a) S. Lou and G. C. Fu, J. Am. Chem. Soc., 2010, 132, 1264;
(b) P. M. Lundin, J. Esquivias and G. C. Fu, Angew. Chem.,
Int. Ed., 2009, 48, 154.
5 A. H. Cherney, N. T. Kadunce and S. E. Reisman, J. Am.
Chem. Soc., 2013, 135, 7442.
6 (a) C. H. Cheon, O. Kanno and F. D. Toste, J. Am. Chem.
Soc., 2011, 133, 13248; (b) B. C. Kang, D. G. Nam,
G.-S. Hwang and D. H. Ryu, Org. Lett., 2015, 17, 4810;
(c) M. Brown, R. Kumar, J. Rehbein and T. Wirth, Chem. –
Eur. J., 2016, 22, 4030; (d) R. Doran and P. J. Guiry, J. Org.
Chem., 2014, 79, 9112.
7 For umpolung reactions at the α-carbon of carbonyl com-
pounds, see: O. Miyata, T. Miyoshi and M. Ueda, ARKIVOC,
2013, 60.
actions with the triphenylaluminium moiety coordinated with
the oxygen atoms of the two ethers in the chiral auxiliary.
We next examined the asymmetric α-phenylation of biologi-
cally active compounds. The nonacidic NSAID nabumetone
and the phosphodiesterase inhibitor pentoxifylline were
selected for our asymmetric umpolung reaction (Scheme 3).
The asymmetric introduction of a phenyl group into these
compounds was successfully achieved to obtain the corres-
ponding α-phenylated ketones 2r and 2s in moderate yields,
with moderate to good enantioselectivities. Therefore, our pro-
tocol can provide an expedient approach to enantioenriched
α-phenylmethyl ketones.
It is worth mentioning that the scalable synthesis of
α-phenyl ketone 2a was performed under optimized con-
ditions, and the desired 2a was obtained in 56% yield with
94% ee when the amount of 1a was increased to 3 mmol
(Scheme 4). The synthetic utility of the current method was
demonstrated by applying it to the preparation of optically
active phenyl-containing compounds (Scheme 4). The treat-
ment of 2a with methylmagnesium bromide gave methylated
tertiary alcohol 4 in good yield, without a noticeable loss of ee.
The effective reduction of 2a by treatment with NaBH4
8 For
α-arylation
of
carbonyl
compounds,
see:
(a) D. A. Culkin and J. F. Hartwig, Acc. Chem. Res., 2003, 36,
234; (b) C. C. C. Johansson and T. J. Colacot, Angew. Chem.,
Int. Ed., 2010, 49, 676.
gave secondary alcohol
diastereoselectivity.18
5
in high yield with high
9 (a) T. Miyoshi, T. Miyakawa, M. Ueda and O. Miyata,
Angew. Chem., Int. Ed., 2011, 50, 928; (b) T. Miyoshi,
S. Sato, H. Tanaka, C. Hasegawa, M. Ueda and O. Miyata,
Tetrahedron Lett., 2012, 53, 4188; (c) T. Miyoshi,
N. Takeda, M. Fukami, S. Sato, M. Ueda and O. Miyata,
Chem. Pharm. Bull., 2014, 62, 927; (d) R. K. Nandi,
N. Takeda, M. Ueda and O. Miyata, Tetrahedron Lett.,
2016, 57, 2269; (e) N. Takeda, E. Futaki, Y. Kobori,
M. Ueda and O. Miyata, Angew. Chem., Int. Ed., 2017, 56,
16342.
Conclusions
In summary, we have developed an asymmetric umpolung
reaction of methyl ketones to prepare α-phenylated ketones
with high enantioselectivities. This straightforward method
provides rapid access to enantioenriched α-phenylated ketones
via a simple operation. Further studies to improve the enantio- 10 For examples of asymmetric α-oxylation and α-amination of
selectivity and extend the catalytic protocol are in progress.
ketones and their equivalents see: (a) B. Basdevant and
8942 | Org. Biomol. Chem., 2018, 16, 8940–8943
This journal is © The Royal Society of Chemistry 2018